Projects funded by the NCN
5-HT6 receptor ligands as addition to antipsychotic therapy in schizophrenia - an impact on body weight, metabolic parameters, cognition and mood impairments
2015/19/B/NZ7/00227
Keywords:
antipsychotic therapy 5-HT6 receptor agonist 5-HT6 receptor antagonist weight gain cognition impairment depression anxiety
Descriptors:
- NZ5_7: Human disease treatment
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 10 - announced on 2015-09-15
Amount awarded: 1 033 800 PLN
Project start date (Y-m-d): 2016-06-20
Project end date (Y-m-d): 2021-06-19
Project duration:: 60 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.